This company provides oral cancer screenings, likely using technology or a specific methodology to detect early signs of the disease. The screenings aim to improve early detection rates and patient outcomes for oral cancer.
Funding
Funding not disclosed
Founders
Product
Problem
Existing oral cancer detection methods often rely on visual inspection, which can be inaccurate, or expensive molecular testing, which limits broad adoption by dentists and patients. This can lead to delayed diagnoses and poorer patient outcomes.
Solution
Wisdom Bioscience offers an advanced oral cancer test designed to detect early signs of the disease. Their approach utilizes existing biomarkers and technology to provide an early indication of elevated risk. The company aims to enable broad adoption of gold-standard molecular testing for oral cancer, with little or no cost to dentists or patients.
Target Audience
The primary target audience includes dentists and patients seeking accessible and accurate oral cancer screening.
Features
- State-of-the-art oral cancer test for early detection
- Utilizes existing biomarkers and technology
- Aims for broad adoption through cost-effectiveness
- IP protected approach